Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Moderna
MRNA
|
+$887M |
| 2 |
Amazon
AMZN
|
+$857M |
| 3 |
Apple
AAPL
|
+$844M |
| 4 |
Microsoft
MSFT
|
+$802M |
| 5 |
Tesla
TSLA
|
+$606M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$760M |
| 2 |
MXIM
Maxim Integrated Products
MXIM
|
+$515M |
| 3 |
WORK
Slack Technologies, Inc.
WORK
|
+$258M |
| 4 |
Oracle
ORCL
|
+$126M |
| 5 |
PFPT
Proofpoint, Inc.
PFPT
|
+$124M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.53% |
| 2 | Financials | 13.97% |
| 3 | Healthcare | 13.42% |
| 4 | Consumer Discretionary | 11.85% |
| 5 | Communication Services | 10.14% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CDAK
3076
DELISTED
Codiak BioSciences, Inc. Common Stock
CDAK
| $3.75M | ﹤0.01% |
229,941
+23,364
| +11% | +$418K |
|
3077
SSR Mining
SSRM
$6.49B
| $3.75M | ﹤0.01% |
257,614
+18,659
| +8% | +$296K |
|
3078
Lifetime Brands
LCUT
$219M
| $3.73M | ﹤0.01% |
205,360
+9,198
| +5% | +$154K |
|
3079
TFI International
TFII
$12B
| $3.73M | ﹤0.01% |
35,810
+348
| +1% | +$37.2K |
|
|
SQZ
3080
DELISTED
SQZ Biotechnologies Company
SQZ
| $3.73M | ﹤0.01% |
259,049
+13,941
| +6% | +$189K |
|
3081
First Bank
FRBA
$471M
| $3.73M | ﹤0.01% |
264,865
+5,631
| +2% | +$75.2K |
|
3082
The ONE Group
STKS
$56.5M
| $3.73M | ﹤0.01% |
349,026
+12,954
| +4% | +$134K |
|
|
TRVN
3083
DELISTED
Trevena, Inc.
TRVN
| $3.73M | ﹤0.01% |
4,846
+491
| +11% | +$416K |
|
|
LBC
3084
DELISTED
Luther Burbank Corporation Common Stock
LBC
| $3.72M | ﹤0.01% |
277,776
+6,719
| +2% | +$85.5K |
|
|
POSH
3085
DELISTED
Poshmark, Inc. Class A Common Stock
POSH
| $3.72M | ﹤0.01% |
156,674
+18,959
| +14% | +$607K |
|
3086
NN Inc
NNBR
$298M
| $3.72M | ﹤0.01% |
708,133
-35,422
| -5% | -$213K |
|
3087
Ericsson
ERIC
$33.4B
| $3.71M | ﹤0.01% |
331,391
+606
| +0.2% | +$7.16K |
|
3088
DarioHealth
DRIO
$72.9M
| $3.71M | ﹤0.01% |
13,584
+2,349
| +21% | +$678K |
|
3089
Powell Industries
POWL
$7.43B
| $3.71M | ﹤0.01% |
452,604
-13,425
| -3% | -$121K |
|
3090
Donegal Group Class A
DGICA
$692M
| $3.7M | ﹤0.01% |
255,399
+5,436
| +2% | +$81.8K |
|
3091
Capital Bancorp
CBNK
$617M
| $3.69M | ﹤0.01% |
153,561
+4,503
| +3% | +$101K |
|
|
NUVL
3092
DELISTED
Nuvalent
NUVL
| $3.69M | ﹤0.01% |
+163,835
| New | +$4.75M |
|
|
BHR
3093
Braemar Hotels & Resorts
BHR
$139M
| $3.69M | ﹤0.01% |
760,041
+88,110
| +13% | +$460K |
|
|
EVLO
3094
DELISTED
Evelo Biosciences, Inc. Common Stock
EVLO
| $3.67M | ﹤0.01% |
26,036
+2,429
| +10% | +$481K |
|
3095
Park-Ohio Holdings
PKOH
$716M
| $3.66M | ﹤0.01% |
143,264
-1,922
| -1% | -$52.2K |
|
3096
Safe Bulkers
SB
$760M
| $3.63M | ﹤0.01% |
703,254
+4,576
| +0.7% | +$17.7K |
|
3097
State Street SPDR S&P 500 ETF Trust
SPY
$815B
| – | – |
0
| – | – |
|
3098
YPF Sociedad Anonima American Depositary Shares (Each representing ten (10) Class D shares of Capital Stock)
YPF
$19.2B
| $3.63M | ﹤0.01% |
785,582
+171,379
| +28% | +$801K |
|
|
KG
3099
Kestrel Group
KG
$66.3M
| $3.63M | ﹤0.01% |
57,360
+2,118
| +4% | +$139K |
|
3100
AgEagle Aerial Systems
UAVS
$62.7M
| $3.62M | ﹤0.01% |
1,204
+211
| +21% | +$784K |
|
Similar funds
Geode Capital Management's Q3 2021 Portfolio in Review
As of Q3 2021, Geode Capital Management held 4,944 positions worth $743B, up 2.3% from $726B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Geode Capital Management's Q3 2021 filing shows 223 new, 2,961 increased, 1,210 reduced and 86 closed positions. Its largest new stake was Lucid Motors: 565,353 shares worth $143M. The largest sale was Alexion Pharmaceuticals, an estimated $760M.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 24% a quarter earlier, followed by Financials and Healthcare.
- Geode Capital Management's largest Q3 2021 buy was Lucid Motors: 565,353 shares worth $143M.
- Geode Capital Management added most to Moderna in Q3 2021, an estimated $887M increase.
- Geode Capital Management's biggest Q3 2021 reduction was Oracle, cutting an estimated $126M.
- Geode Capital Management fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $760M.
- Geode Capital Management's ten largest holdings make up 23% of its $743B portfolio in Q3 2021.
- Geode Capital Management opened 223 new positions and closed 86 in Q3 2021.
- Geode Capital Management's portfolio value rose 2.3% quarter-over-quarter to $743B.
Based on Geode Capital Management's 13F filing for Q3 2021, filed 12 Nov 2021.